Xu Jiandong has filed 3 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 490796 shares of Estrella Immunopharma, Inc. ($ESLA) on October 30, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 30, 2024 | Estrella Immunopharma, Inc. | $ESLA | Xu Jiandong | Chief Financial Officer | A | Incentive Share Option | 490796 | $0.00 | 490,796.0000 | 36,208,477 | 9999.99% | 1.36% |
| Oct. 30, 2024 | Estrella Immunopharma, Inc. | $ESLA | Xu Jiandong | Chief Financial Officer | A | Nonstatutory Share Option | 509204 | $0.00 | 509,203.0000 | 36,208,477 | 0.00% | 1.41% |
| Aug. 30, 2024 | Semnur Pharmaceuticals, Inc. | $SMNR | Xu Jiandong | TenPercentOwner | S | Class B Ordinary Shares | 500000 | $0.00 | 1,432,500.0000 | 0 | 25.87% | 0.00% |